[go: up one dir, main page]

GB9101774D0 - Agent for use in the prevention control or reversal of hypertension - Google Patents

Agent for use in the prevention control or reversal of hypertension

Info

Publication number
GB9101774D0
GB9101774D0 GB919101774A GB9101774A GB9101774D0 GB 9101774 D0 GB9101774 D0 GB 9101774D0 GB 919101774 A GB919101774 A GB 919101774A GB 9101774 A GB9101774 A GB 9101774A GB 9101774 D0 GB9101774 D0 GB 9101774D0
Authority
GB
United Kingdom
Prior art keywords
hypertension
reversal
agent
prevention control
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB919101774A
Other versions
GB2240472A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perrigo Co PLC
Original Assignee
Elan Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Corp PLC filed Critical Elan Corp PLC
Publication of GB9101774D0 publication Critical patent/GB9101774D0/en
Publication of GB2240472A publication Critical patent/GB2240472A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9101774A 1990-01-29 1991-01-28 Agent for use in the prevention, control or reversal of hypertension Withdrawn GB2240472A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE030690A IE900306A1 (en) 1990-01-29 1990-01-29 Agent for use in the prevention, control or reversal of¹hypertension

Publications (2)

Publication Number Publication Date
GB9101774D0 true GB9101774D0 (en) 1991-03-13
GB2240472A GB2240472A (en) 1991-08-07

Family

ID=11010198

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9101774A Withdrawn GB2240472A (en) 1990-01-29 1991-01-28 Agent for use in the prevention, control or reversal of hypertension

Country Status (3)

Country Link
GB (1) GB2240472A (en)
IE (1) IE900306A1 (en)
ZA (1) ZA91614B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU676470B2 (en) * 1992-02-24 1997-03-13 East Carolina University Method of inhibiting carcinogenesis by treatment with dehydroepiandrosterone and analogs thereof
US7893044B2 (en) 1995-02-24 2011-02-22 Epigenesis Pharmaceutical, Inc. Composition and method for altering levels of or sensitivity to adenosine with analogs of dehydroepiandrosterone
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
FR2803519B1 (en) * 2000-01-12 2002-03-22 Assist Publ Hopitaux De Paris ORAL USE OF DEHYDROEPIANDROSTERONE, ITS PRECURSORS AND DERIVATIVES FOR IMPROVING THE PAPYRACE OF THE SKIN
ES2545337T3 (en) * 2011-07-19 2015-09-10 Pantarhei Bioscience B.V. Tablet containing dehydroepiandrosterone (DHEA)

Also Published As

Publication number Publication date
GB2240472A (en) 1991-08-07
IE900306A1 (en) 1991-07-31
ZA91614B (en) 1991-10-30

Similar Documents

Publication Publication Date Title
IL101038A0 (en) Agent specific for trombin and its use
GB9121289D0 (en) Composition and use
EP0654252A3 (en) Dental prophylaxis and water conservation device.
GB9101774D0 (en) Agent for use in the prevention control or reversal of hypertension
GB9102796D0 (en) Water treatment agent
ZA924491B (en) Compositions and use thereof
GB9013393D0 (en) Multipurpose attachment for excavators and the like
GB9222985D0 (en) Use of the tarchonanthus camphoratus
ZA921137B (en) Composition and use
EP0459660A3 (en) Halopropargyl compounds and the use thereof as microbicides
GB9016027D0 (en) Composition and use
HK1014195A1 (en) Polyamide composition and the use
IL105873A0 (en) Pyrimidinyl-and triazinyl-salicyl-and-picolyl-amides and the use and preparation thereof
GB9209048D0 (en) Improvements in or relating to sewers and the like
GB9314512D0 (en) Composition and use
EP0594211A3 (en) Aqueous organosiloxane liquid composition and its use.
GB2245633B (en) Glazing and the like
GB9306456D0 (en) Composition and use
GB9408859D0 (en) Composition and use
SG49175A1 (en) Pyridinecarboximidamide compounds and the use thereof
GB9315783D0 (en) Ropes and the use thereof
GB9200474D0 (en) Improvements in the construction of structures
GB9009530D0 (en) Composition and use
GB9116906D0 (en) Composition and use
CA73431S (en) Tub or the like

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)